Skip to Main

2025 Article Archive

UTSW discovery opens door to novel strategies for hard-to-treat cancers

 

UT Southwestern Medical Center researchers have identified two distinct populations of cells known as antigen-presenting cancer-associated fibroblasts (apCAFs) that appear to support the survival and growth of malignant tumors. Their findings, reported in Cancer Cell, could one day lead to new therapies for notoriously hard-to-treat cancers, including pancreatic cancer and advanced colorectal cancer (CRC) that has spread throughout the abdomen, known as peritoneal metastasis.

UT Southwestern and Children’s Health receive $25 million from the Harry W. Bass, Jr. Foundation for new pediatric campus

 

UT Southwestern Medical Center and Children’s Health announced a $25 million gift from the Harry W. Bass, Jr. Foundation, directed through Southwestern Medical Foundation, in support of their $5 billion transformative joint pediatric campus under construction in Dallas’ Southwestern Medical District across from UTSW’s William P. Clements Jr. University Hospital.

New CEO to lead UTSW’s Clements University Hospital

 

Traci d’Auguste, M.B.A., M.S.H.A., who has more than two decades of leadership experience in academic medicine, is the new Vice President and Chief Executive Officer of UT Southwestern Medical Center’s William P. Clements Jr. University Hospital (CUH), effective today.

Two UT Southwestern scientists named Clarivate Citation Laureates

 

Two UT Southwestern Medical Center scientists – Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research, and Michael Rosen, Ph.D., Chair and Professor of Biophysics – have been selected as 2025 Citation Laureates in recognition of work deemed by Clarivate to be of the highest impact.

Targeted therapy helps NICU parents reframe fears

 

A cognitive behavioral therapy (CBT) program developed for parents whose child was born prematurely reduced harmful perceptions that their child remained medically fragile, according to a new study led by UT Southwestern Medical Center.

UTSW Research: Diagnosing Alzheimer’s, timed radiation therapy, and more

 

Studies look at measuring blood flow velocity, a treatment strategy for non-small cell lung cancer, and the body’s response to airborne pathogens.

Food as medicine: UTSW advances clinical nutrition care

 

A novel clinical pilot program at UT Southwestern Medical Center is transforming the role of nutrition education in patient care.

UTSW named Specialized Program of Research Excellence for liver cancer

 

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).

Biomarkers linked to side effects from cancer immunotherapy

 

A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.

Higher dose of semaglutide increases weight loss, metabolic benefits

 

Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows.